Issue link: https://www.e-digitaleditions.com/i/1521797
An article provides an overview of nasal powder formulations, which represent a significant stride in drug delivery innovation and take advantage of the nasal passages as a convenient, needle-free route for systemic and CNS drug delivery. Another article presents two case studies of nasal powders, where different particle engineering and formulation strategies were evaluated, focusing on nasal delivery of poorly soluble drugs. 2 June 2024 Inhalation Inhalation (ISSN 1940-414X digital) is published seven times per year in January, February, April, June, August, October and December by Whipsnade and Loophole, LLC, P.O. Box 27092, Minneapolis, MN 55427 US. w w w . i n h a l a t i o n m a g . c o m June 2024 Volume 18 Number 3 The cover photo shows aerodynamic particle size distribution (APSD) testing, critical in the development and routine analysis of dry power inhaler products. Photo courtesy of Intertek Melbourn, Saxon Way, Melbourn, Hertfordshire, SG8 6DN, United Kingdom, Tel.: +44 1763 261648, bd.melbourn@intertek. com, www.intertek.com nasal delivery, nebulizers and soft mist inhalers 10 Nasal powder: A stable, rapid-onset strategy for systemic therapy William Wei Lim Chin, Michael A. Sandoval and Alan B. Watts 20 Issue focus: Nasal delivery, nebulizers and soft mist inhalers 24 Amorphous solid dispersions for nasal delivery Patrícia Henriques and Slavomíra Doktorovová filling and packaging 32 Special section: Filling and packaging additional features 6 Cross-industry organizations: Drug Delivery to the Lungs: Highlights of DDL2023 and a preview of DDL2024 31 Previewing RDD ® Asia 2024 38 Back page: Why are disproportionately impacted communities underrepresented in food allergy clinical trials? departments 8 Industry news 35 Respiratory medicine news 35 Calendar 36 Products and services review